Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China

• by Honghong Yang, Qing Yu, Mei Li, Min Liu

• June 9, 2026

Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

• by Kaltham Al-Shaibah, Reham Jasem, Ali Alsarhan, Christos Tzivinikos

• June 8, 2026

Vaccine Analysis for a New Era

As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing

• June 8, 2026

• 11 min

Italian healthcare professionals' real-world experience with immunization in children of non-European origin: the Vax4globe survey

• by Viviana Moschese, Simona Graziani, Antonietta Spadea, Maurizia D’Amore, Raffaella Mosco, Sara Ciampini, Nicola Di Giorgio, Susanna Arcano, Simona Ceccarelli, Marco Chianca, Simona Piccinini, Antonella Polito, Marta Porcari, Pamela Puliafito, Romina Silenzi, Elisabetta Del Duca, Alfonso Piciocchi, Claudio Pignata, Michele Miraglia Del Giudice, Gian Luigi Marseglia, the Italian Society of Pediatric Research (SIRP) and the Italian Society of Pediatric Allergy and Immunology (SIAIP) Vaccine Committee

• June 9, 2026